Alzheimer Patient (Alzheimer Disease) Equipment
-
Manufactured by MagQu LLC USAbased in USA
Amyloid β (Aβ or Abeta) denotes peptides of 36–43 amino acids that are crucially involved in Alzheimer's disease as the main component of the amyloid plaques found in the brains of Alzheimer patients. The peptides result from the amyloid precursor protein (APP), which is being cut by certain enzymes to yield Aβ. ...
-
Manufactured by MagQu LLC USAbased in USA
disease as the main component of the amyloid plaques found in the brains of Alzheimer patients. The peptides result from the amyloid precursor protein (APP), which is being cut by certain enzymes to yield Aβ. One of the most common isoforms is ...
-
by Theramx Inc.based in SOUTH KOREA
Technology that excavates biomarkers through an analysis of brainwaves in epilepsy or Alzheimer’s patients, predicts the likelihood of onset, or diagnoses the advance, based on the degree of change of brainwave biomarkers measured by a wearable EEG (AI-electroencephalogram) measuring instrument allowing. ...
-
Manufactured by Provista Diagnosticsbased in USA
The Lymphocyte Proliferation (LymPro) Test™ measures the immune proliferative response of white blood cells to mitogenic stimulation. Based on differences observed in the response of cells from patients with Alzheimer’s disease as compared with age-matched controls and patients with other dementias, it appears that the test has ...
-
Manufactured by Silverts Adaptive LLCbased in CANADA
Senior Men's Stay Dressed Jumpsuit is ideal for assisted dressing. This jumpsuit was thoughtfully designed to discourage sporadic undressing with the styling of two pieces for a discrete and conventional look. This jumpsuit features a long, secure back zipper with snap tab closure for caregivers to easily secure this handicap garment. It also features a soft, pique top and cotton twill bottom ...
-
Manufactured by BioXcel Therapeutics, Inc.based in USA
BXCL501 is our most advanced neuroscience clinical program. BXCL501 is a proprietary, sublingual film formulation of dexmedetomidine, a selective alpha-2 receptor agonist. It is being investigated for at-home use for the acute treatment of agitation in bipolar and schizophrenia patients, for agitation in Alzheimer’s ...
-
Manufactured by BioArctic ABbased in SWEDEN
AD1801 is an innovative project to develop disease modifying treatment of Alzheimer’s disease, targeting Apolipoprotein E (ApoE), a different molecule than those targeted in the projects BAN2401 and BAN2401 ...
-
based in USA
and a sense of wellbeing for patients battling brain disease. ...
-
Manufactured by Lafayette Instrument Companybased in USA
The Second Generation Bussey Chambers with Intelli-interface supports up to 20 chambers on one PC. On the strength of 10 years of feedback and development, the system is even more flexible and with more ...
-
Manufactured by Alzinova ABbased in SWEDEN
ALZ-101 is a vaccine that stimulates the production of antibodies against the toxic Aβ oligomers. A first-in-human study in patients with early Alzheimer’s disease was initiated during third quarter of ...
-
Manufactured by BioArctic ABbased in SWEDEN
Research to develop new antibodies for treating neurodegenerative disorders is under way at BioArctic. the ND3014 project aims to develop selective antibody treatments targeting TDP-43, a protein that is believed to play a crucial role in the development of the rare neurodegenerative disease ALS (amyotrophic lateral ...
-
Manufactured by BioArctic ABbased in SWEDEN
In Alzheimer’s disease soluble, toxic amyloid beta aggregates are believed to contribute to the neurodegenerative process. Lecanemab, a anti amyloid-beta protofibril antibody, selectively binds to these forms of amyloid beta and eliminates them. The antibody’s unique profile is highly selective for amyloid beta ...
-
Manufactured by Firalis Groupbased in FRANCE
NEUROLINCS : A non-invasive in-vitro diagnostic test measuring 7494 brain-enriched long non-coding RNAs (lncRNAs) that are specific to neurodegenerative ...
-
Manufactured by BioArctic ABbased in SWEDEN
BioArctic has developed a technology platform that has proven to be successful when the company’s first drug candidate was developed, the antibody BAN2401 for Alzheimer´s disease. Our mission is to improve quality of life for patients suffering from Central Nervous System (CNS) disorders. Patients with neurodegenerative disorders ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you